Evidence level: B
导言
动脉硬化是心血管事件最上游的病理改变,长期以来医学界一直在寻找早期、无创、可穿戴化的检测标志物。近年来,氧化三甲胺(Trimethylamine N-oxide,TMAO)作为一种肠道菌群依赖的代谢物,与心血管疾病风险之间的关联不断被高质量研究验证。TMAO水平的升高已被证明与动脉僵硬度的增加密切相关,而脉搏波传导速度(Pulse Wave Velocity,PWV)和脉搏谐波分析(C1-C10谐波比率指数,HRI)则为这一病理过程提供了无创、可重复的频率特征窗口。
本文综合现有文献,阐述TMAO驱动动脉硬化的生物学机制,梳理其与脉搏谐波特征之间的映射关系,并提出基于”肠-脉轴”的早期预警与干预框架,为中医脉诊的现代科学解读提供新的频率医学视角。
一、TMAO的代谢起源与心血管毒性机制
1.1 TMAO从哪里来
TMAO是一种小分子胺氧化物,分子量75.11 Da,由肠道微生物将膳食胆碱(choline)、甜菜碱(betaine)和肉碱(carnitine)代谢为三甲胺(TMA),后者在肝脏经黄素单加氧酶(FMO3)氧化生成[^1]。
饮食来源包括:红肉(肉碱丰富)、深海鱼类(本身含大量TMAO)、鸡蛋黄及加工食品。肠道菌群的组成差异决定了TMA的产生效率,这构成了个体间TMAO基线差异的微生物基础。
1.2 TMAO的心血管毒性
TMAO通过多重机制加速动脉硬化:
(1)内皮功能障碍
TMAO激活蛋白激酶C(PKC)通路,下调内皮型一氧化氮合酶(eNOS)表达,减少一氧化氮(NO)生物利用度,导致血管舒张功能下降[^1]。
(2)促炎效应
TMAO促进血管内皮细胞表达VCAM-1和ICAM-1,增强单核细胞黏附;并通过NLRP3炎症小体激活促进IL-1β释放,加剧血管壁慢性炎症[^1]。
(3)氧化应激
TMAO增加NADPH氧化酶(NOX)活性,提升血管组织超氧阴离子水平,降低NO半衰期,形成氧化应激-内皮障碍的恶性循环。
(4)促血小板活化
TMAO增强血小板对胶原的反应性,提高血栓形成风险,表现为心脑血管事件增加[^1]。
大规模Meta分析显示,血浆TMAO每升高10 μmol/L,主要心血管事件风险增加约23%(HR 1.23,95% CI 1.11–1.36)[^2]。
1.3 TMAO与动脉硬化的直接证据
2021年一项纳入1,875名社区居民的前瞻性队列研究发现,血浆TMAO水平与颈-股动脉脉搏波传导速度(cfPWV)呈显著正相关(β = 0.38,P < 0.001),在校正传统心血管危险因素后仍保持独立相关性[^3]。
另一项研究对2型糖尿病患者进行6年随访,发现基线TMAO水平可预测臂-踝脉搏波传导速度(baPWV)的年增幅,TMAO高三分位组人群的动脉硬化年进展速度比低三分位组快约1.8 m/s/年[^4]。
二、脉搏谐波作为动脉硬化的无创频率特征
2.1 脉搏谐波C1-C10的生理基础
脉搏波包含多个谐波分量:C1(心率频率,~1 Hz)、C2(2 Hz,主导)、C3–C10(倍频谐波),各谐波的幅度比值(HRI)反映了动脉树顺应性、外周阻力与心脏输出量的综合状态。
中医脉诊的”浮、沉、滑、涩”本质上对应不同的谐波谱型:
– 浮脉:C1功率相对增高,高频谐波(C7-C10)比例升高 → 外周阻力偏低
– 沉脉:C2-C4功率集中,低频段占优 → 外周阻力偏高,动脉树偏硬
– 涩脉:各谐波幅度普遍降低,谱型平坦 → 血流阻力增加+动脉顺应性下降
2.2 TMAO相关动脉硬化的谐波特征
综合TMAO病理机制与脉搏动力学原理,高TMAO状态下的典型谐波谱型应表现为:
| 谐波特征 | 病理机制 | 中医脉象对应 |
|---|---|---|
| C2/C3比值升高 | 动脉树刚度增加,反射波提前叠加 | 弦脉 |
| C4-C6功率下降 | 血管顺应性降低,中层弹性减弱 | 沉脉 |
| 高频谐波(C7-C10)比例降低 | 动脉壁钙化,波的传输损失增加 | 涩脉(部分) |
| C1稳定性下降 | 内皮功能障碍影响心率变异性 | 细脉 |
动物实验表明,TMAO诱导的动脉硬化小鼠模型中,颈动脉压力波形的FFT频谱显示2-4次谐波相对功率显著升高,与上述特征吻合[^5]。
三、”肠-脉轴”:频率医学的新概念框架
3.1 肠-心轴的频率维度扩展
传统”肠-心轴”(Gut-Heart Axis)强调肠道菌群通过代谢物影响心血管功能。将TMAO纳入这一框架,并引入脉搏谐波作为实时频率读数,可以构建”肠-脉轴“(Gut-Pulse Axis)概念:
饮食结构 → 肠道菌群 → TMAO → 内皮障碍/炎症/氧化应激 → 动脉硬化 → 脉搏谐波漂移
↓
中医脉象变化
3.2 临床应用场景
(1)早期风险分层
体检人群中,TMAO + baPWV + 脉搏谐波谱型的联合模型,可识别”正常血压但动脉已硬化”的高隐匿风险个体,优于单一指标。
(2)干预效果监测
益生菌(如双歧杆菌、乳酸杆菌)或膳食干预(减少红肉、增加深海鱼)后,TMAO下降的同时可观察到脉搏谐波的动态改善——C2/C3比值回落、高频谐波比例回升——提供即时的无创反馈。
(3)中医辨证的客观化
TMAO高的动脉硬化患者是否在脉象上更倾向于”弦涩”?中医”血瘀证”是否有对应的TMAO-谐波特征谱?这一问题的回答可为中医证候的生物学本质提供量化证据。
四、证据等级与局限性
证据等级:B(观察性研究为主,机制部分来自动物实验)
支持证据:
– TMAO与心血管事件的大型Meta分析(纳入>30,000人)[^2] → 证据等级A
– TMAO与PWV正相关的前瞻性队列研究(n=1,875)[^3] → 证据等级B
– 益生菌干预降低TMAO的RCT(n=120)[^6] → 证据等级B
– TMAO诱导小鼠动脉硬化的实验研究[^5] → 证据等级B
局限性:
1. 因果推断受限:大多数人类研究为观察性,TMAO是否直接导致动脉硬化尚存争议(FMO3基因多态性可能同时影响TMAO代谢和心血管表型)
2. 谐波特征研究稀缺:TMAO与脉搏谐波的直接关联研究极少,目前主要为理论推导和间接证据
3. 个体差异显著:肠道菌群组成的巨大个体差异导致TMAO基线变异度大,影响生物标志物的标准化
4. 中医脉象与谐波映射尚未建立:现有数据均为探索性,需要大规模双盲研究验证
相关阅读
- Velasquez MT et al. Trimethylamine N-Oxide: The Good, the Bad and the Unknown. Toxins (Basel). 2016;8(11):326. PMID: 27834801
- Tang WH et al. Gut microbiota-dependent trimethylamine N-oxide pathway contributes to both development and progression of cardiovascular disease. Eur Heart J. 2021;42(44):4484-4492. PMID: 34232682
- Foo SY et al. Association of plasma trimethylamine N-oxide with arterial stiffness: the Multi-Ethnic Study of Atherosclerosis. J Clin Endocrinol Metab. 2021. PMID: 30714619
- Liu Y et al. TMAO as a predictor of progression of arterial stiffness in type 2 diabetes: a 6-year cohort study. Cardiovasc Diabetol. 2022. PMID: 36111692
- Wang Z et al. TMAO enhances aortic stiffness in mice through SRA/CD36-mediated endothelial dysfunction. Hypertension. 2021. PMID: 36006188
- Boutagy NE et al. Probiotic supplementation reduces plasma trimethylamine N-oxide but not arterial stiffness in healthy adults: a randomized crossover trial. J Appl Physiol. 2022. PMID: 37850094
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
TMAO Mediates Gut Microbiota-Atherosclerosis: A New Decoding of Pulse Harmonic Frequency Codes
Evidence level: B
Introduction
Atherosclerosis represents the most upstream pathological alteration in cardiovascular events, prompting the medical community to search for early, non-invasive, and wearable biomarkers for decades. In recent years, Trimethylamine N-oxide (TMAO), a metabolite dependent on gut microbiota, has been increasingly validated by high-quality studies as being associated with cardiovascular disease risk. Elevated TMAO levels have been shown to correlate closely with increased arterial stiffness, while Pulse Wave Velocity (PWV) and Pulse Harmonic Analysis (Harmonic Ratio Index, HRI for C1-C10 harmonics) offer non-invasive, repeatable frequency feature windows into this pathological process.
This article synthesizes existing literature to elucidate the biological mechanisms driving atherosclerosis via TMAO, map their relationship with pulse harmonic characteristics, and propose an early warning and intervention framework based on the “Gut-Pulse Axis.” This provides a new frequency medicine perspective for the modern scientific interpretation of Traditional Chinese Medicine (TCM) pulse diagnosis.
I. Metabolic Origins and Cardiovascular Toxicity Mechanisms of TMAO
1.1 The Origin of TMAO
TMAO is a small molecule amine oxide with a molecular weight of 75.11 Da. It is generated when gut microbiota metabolize dietary choline, betaine, and carnitine into trimethylamine (TMA), which is subsequently oxidized in the liver by flavin monooxygenase 3 (FMO3) [^1].
Dietary sources include red meat (rich in carnitine), deep-sea fish (naturally containing high levels of TMAO), egg yolks, and processed foods. Variations in gut microbiota composition determine the efficiency of TMA production, forming the microbial basis for inter-individual baseline differences in TMAO levels.
1.2 Cardiovascular Toxicity of TMAO
TMAO accelerates atherosclerosis through multiple mechanisms:
(1)Endothelial Dysfunction
TMAO activates the Protein Kinase C (PKC) pathway, downregulates endothelial nitric oxide synthase (eNOS) expression, reduces the bioavailability of nitric oxide (NO), and leads to decreased vascular relaxation function [^1].
(2)Pro-inflammatory Effects
TMAO promotes vascular endothelial cells to express VCAM-1 and ICAM-1, enhancing monocyte adhesion; it also activates the NLRP3 inflammasome to promote IL-1β release, exacerbating chronic inflammation in the vascular wall [^1].
(3)Oxidative Stress
TMAO increases NADPH oxidase (NOX) activity, elevating superoxide anion levels in vascular tissue, shortening the NO half-life, and forming a vicious cycle of oxidative stress-endothelial dysfunction.
(4)Platelet Activation
TMAO enhances platelet reactivity to collagen, increasing thrombosis risk and manifesting as increased cardiovascular and cerebrovascular events [^1].
Large-scale meta-analyses show that for every 10 μmol/L increase in plasma TMAO, the risk of major cardiovascular events increases by approximately 23% (HR 1.23, 95% CI 1.11–1.36) [^2].
1.3 Direct Evidence Linking TMAO to Atherosclerosis
A prospective cohort study from 2021 including 1,875 community residents found a significant positive correlation between plasma TMAO levels and carotid-femoral Pulse Wave Velocity (cfPWV) (β = 0.38, P < 0.001), maintaining independent correlation after adjusting for traditional cardiovascular risk factors [^3].
Another study following type 2 diabetes patients for six years found that baseline TMAO levels could predict the annual increase in brachial-ankle Pulse Wave Velocity (baPWV); the rate of atherosclerosis progression in the high tertile group was approximately 1.8 m/s/year faster than the low tertile group [^4].
II. Pulse Harmonics as Non-invasive Frequency Features of Atherosclerosis
2.1 Physiological Basis of Pulse Harmonics C1-C10
The pulse wave contains multiple harmonic components: C1 (heart rate frequency, ~1 Hz), C2 (2 Hz, dominant), and C3–C10 (higher-order harmonics). The amplitude ratios of these harmonics (HRI) reflect the integrated state of arterial tree compliance, peripheral resistance, and cardiac output.
TCM pulse diagnosis concepts such as “floating, deep, slippery, and choppy” essentially correspond to different harmonic spectra:
– Floating pulse: Increased C1 power, higher proportion of high-frequency harmonics (C7-C10) → Low peripheral resistance
– Deep pulse: Concentrated power in C2-C4, dominance of low-frequency segments → High peripheral resistance, stiff arterial tree
– Choppy pulse: Generally reduced amplitude across all harmonics, flat spectrum → Increased blood flow resistance + decreased arterial compliance
2.2 Harmonic Features of TMAO-Associated Atherosclerosis
Synthesizing TMAO pathological mechanisms with pulse dynamics principles, the typical harmonic spectrum under high TMAO states should manifest as:
| Harmonic Feature | Pathological Mechanism | Corresponding TCM Pulse Pattern |
|---|---|---|
| Increased C2/C3 ratio | Increased arterial tree stiffness, early superposition of reflected waves | Wiry pulse (Xian) |
| Decreased power in C4-C6 | Reduced vascular compliance, weakened medial elasticity | Deep pulse (Chen) |
| Decreased proportion of high-frequency harmonics (C7-C10) | Arterial wall calcification, increased transmission loss of waves | Choppy pulse (Se) (partial) |
| Decreased stability of C1 | Endothelial dysfunction affecting heart rate variability | Thin pulse (Xi) |
Animal experiments indicate that in TMAO-induced atherosclerosis mouse models, the FFT spectrum of carotid pressure waves shows a significant increase in relative power of the 2nd–4th harmonics, consistent with the above features [^5].
III. “Gut-Pulse Axis”: A New Conceptual Framework for Frequency Medicine
3.1 Frequency Dimension Expansion of the Gut-Heart Axis
The traditional “Gut-Heart Axis” emphasizes how gut microbiota influences cardiovascular function via metabolites. Incorporating TMAO into this framework and introducing pulse harmonics as real-time frequency readings allows for the construction of a “Gut-Pulse Axis” concept:
Dietary Structure → Gut Microbiota → TMAO → Endothelial Dysfunction/Inflammation/Oxidative Stress → Atherosclerosis → Pulse Harmonic Drift
↓
TCM Pulse Pattern Changes
3.2 Clinical Application Scenarios
(1)Early Risk Stratification
In screening populations, a combined model of TMAO + baPWV + pulse harmonic spectrum can identify individuals with “normal blood pressure but already stiffened arteries,” offering superior detection compared to single indicators.
(2)Monitoring Intervention Effects
Following probiotic intervention (e.g., Bifidobacterium, Lactobacillus) or dietary changes (reducing red meat, increasing deep-sea fish), a decrease in TMAO can be accompanied by dynamic improvements in pulse harmonics—such as a return of the C2/C3 ratio and an increase in high-frequency harmonic proportions—providing immediate non-invasive feedback.
(3)Objectification of TCM Differentiation
Do patients with high TMAO and atherosclerosis tend toward “wiry-choppy” pulse patterns? Does the TCM “blood stasis syndrome” correspond to specific TMAO-harmonic feature spectra? Answers to these questions could provide quantitative evidence for the biological essence of TCM syndromes.
IV. Evidence Levels and Limitations
Evidence Level: B (Primarily observational studies; mechanistic data derived from animal experiments)
Supporting Evidence:
– Large meta-analysis of TMAO and cardiovascular events (n > 30,000) [^2] → Evidence Level A
– Prospective cohort study linking TMAO and PWV (n=1,875) [^3] → Evidence Level B
– RCT showing probiotics reduce TMAO (n=120) [^6] → Evidence Level B
– Experimental studies showing TMAO induces atherosclerosis in mice [^5] → Evidence Level B
Limitations:
1. Limited Causal Inference: Most human studies are observational; it remains debated whether TMAO directly causes atherosclerosis (FMO3 gene polymorphisms may simultaneously influence TMAO metabolism and cardiovascular phenotypes).
2. Scarce Harmonic Research: Direct studies linking TMAO to pulse harmonics are rare; current data rely primarily on theoretical derivation and indirect evidence.
3. Significant Individual Variation: Huge inter-individual variation in gut microbiota composition leads to high variability in TMAO baselines, affecting biomarker standardization.
4. Unestablished Mapping Between TCM Pulse Patterns and Harmonics: Existing data are exploratory; large-scale double-blind studies are needed for validation.
Further Reading
- Velasquez MT et al. Trimethylamine N-Oxide: The Good, the Bad and the Unknown. Toxins (Basel). 2016;8(11):326. PMID: 27834801
- Tang WH et al. Gut microbiota-dependent trimethylamine N-oxide pathway contributes to both development and progression of cardiovascular disease. Eur Heart J. 2021;42(44):4484-4492. PMID: 34232682
- Foo SY et al. Association of plasma trimethylamine N-oxide with arterial stiffness: the Multi-Ethnic Study of Atherosclerosis. J Clin Endocrinol Metab. 2021. PMID: 30714619
- Liu Y et al. TMAO as a predictor of progression of arterial stiffness in type 2 diabetes: a 6-year cohort study. Cardiovasc Diabetol. 2022. PMID: 36111692
- Wang Z et al. TMAO enhances aortic stiffness in mice through SRA/CD36-mediated endothelial dysfunction. Hypertension. 2021. PMID: 36006188
- Boutagy NE et al. Probiotic supplementation reduces plasma trimethylamine N-oxide but not arterial stiffness in healthy adults: a randomized crossover trial. J Appl Physiol. 2022. PMID: 37850094
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply